Elizabeth Helen Barnes

Elizabeth Helen Barnes

Auto-generated profile, based on publicly available information

Elizabeth Helen Barnes

Sydney Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney , Sydney, New South Wales

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
RLRiley Lisa
Riley Lisa
MNMichael Nafisinia
Michael Nafisinia
MMMinal J. Menezes
Minal J. Menezes
RNReta Nambiar
Reta Nambiar
AWAndrew Williams
Andrew Williams
JCJohn Christodoulou
John Christodoulou

13 April 2023 in Journal of Paediatrics and Child Health
Verified
Journal Article
Open access
BYBenedicta Yudianto
Benedicta Yudianto
PCPatrina Caldwell
Patrina Caldwell
RNRalph K. Nanan
Ralph K. Nanan
EBElizabeth H Barnes
Elizabeth H Barnes
KSKaren M Scott
Karen M Scott
Aim: This study aimed to understand parents' online health information‐seeking behaviour and the potential influence of this on their relationship with their child's physician.Methods: A survey regarding parental online health information‐seeking behaviour was administered to parents of children aged under 18 years admitted to an Australian tertiary paediatric hospital, paediatric hospital ward and paediatric clinic, and in their social media networks. Responses were presented as frequencies and percentages. Associations between parents' trust in their child's doctor and survey responses were analysed using χ2 tests.Results: In all, 300 surveys were completed. Most parents (89%) reported searching for online health information when their child was sick. Some (31%) followed online health information instead of going to the doctor. Parents who trusted their child's doctor were more likely to follow the doctor instead of online health information when it contained conflicting advice. Most parents (91%) wanted health‐care professionals' help in searching for online health information.Conclusion: Almost all parents search for online health information, but most do not act on it. Parents' trust in their child's doctor influences how parents use online health information. Thus, clinicians could recommend trustworthy websites with information that complements their advice to ensure parents access reliable online health information.

4 August 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
EKEng-Siew Koh
Eng-Siew Koh
HGHui K Gan
Hui K Gan
CSClare Senko
Clare Senko
RFRoslyn J Francis
Roslyn J Francis
MEMartin Andrew Ebert
Martin Andrew Ebert
Andrew ScottAndrew Scott
Andrew Scott
Introduction: Glioblastoma is the most common aggressive primary central nervous system cancer in adults characterised by uniformly poor survival. Despite maximal safe resection and postoperative radiotherapy with concurrent and adjuvant temozolomide-based chemotherapy, tumours inevitably recur. Imaging with O-(2-[ 18 F]-fluoroethyl)-L-tyrosine (FET) positron emission tomography (PET) has the potential to impact adjuvant radiotherapy (RT) planning, distinguish between treatment-induced pseudoprogression versus tumour progression as well as prognostication. Methods and analysis: The FET-PET in Glioblastoma (FIG) study is a prospective, multicentre, non-randomised, phase II study across 10 Australian sites and will enrol up to 210 adults aged ≥18 years with newly diagnosed glioblastoma. FET-PET will be performed at up to three time points: (1) following initial surgery and prior to commencement of chemoradiation (FET-PET1); (2) 4 weeks following concurrent chemoradiation (FET-PET2); and (3) within 14 days of suspected clinical and/or radiological progression on MRI (performed at the time of clinical suspicion of tumour recurrence) (FET-PET3). The co-primary outcomes are: (1) to investigate how FET-PET versus standard MRI impacts RT volume delineation and (2) to determine the accuracy and management impact of FET-PET in distinguishing pseudoprogression from true tumour progression. The secondary outcomes are: (1) to investigate the relationships between FET-PET parameters (including dynamic uptake, tumour to background ratio, metabolic tumour volume) and progression-free survival and overall survival; (2) to assess the change in blood and tissue biomarkers determined by serum assay when comparing FET-PET data acquired prior to chemoradiation with other prognostic markers, looking at the relationships of FET-PET versus MRI-determined site/s of progressive disease post chemotherapy treatment with MRI and FET-PET imaging; and (3) to estimate the health economic impact of incorporating FET-PET into glioblastoma management and in the assessment of post-treatment pseudoprogression or recurrence/true progression. Exploratory outcomes include the correlation of multimodal imaging, blood and tumour biomarker analyses with patterns of failure and survival. Ethics and dissemination: The study protocol V.2.0 dated 20 November 2020 has been approved by a lead Human Research Ethics Committee (Austin Health, Victoria). Other clinical sites will provide oversight through local governance processes, including obtaining informed consent from suitable participants. The study will be conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice. Results of the FIG study (TROG 18.06) will be disseminated via relevant scientific and consumer forums and peer-reviewed publications. Trial registration number: ANZCTR ACTRN12619001735145


22 May 2017 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KFKathryn M. Field
Kathryn M. Field
MKMadeleine T. King
Madeleine T. King
JSJohn Simes
John Simes
DEDavid Espinoza
David Espinoza
EBElizabeth H. Barnes
Elizabeth H. Barnes
ANAnna K. Nowak
Anna K. Nowak

6 August 2012 in Medical Journal of Australia
Verified
Journal Article
Closed access
MCMonique F Cruz
Monique F Cruz
JEJames Edwards
James Edwards
MDMichael M Dinh
Michael M Dinh
EBElizabeth H Barnes
Elizabeth H Barnes
Objective: To investigate whether bias in clinical history affects accuracy of electrocardiograph (ECG) interpretation among doctors working in emergency departments.Design and setting: Observational study conducted at four teaching hospitals in Sydney from May to September 2011.Participants: Emergency registrars and physicians (senior doctors), and interns, resident medical officers and senior resident medical officers (junior doctors).Intervention: Participants interpreted 30 ECGs ...